
LCQ4: Complaints and enquiries relating to public healthcare fees and charges reform
***************************************************************
Following is a question by the Hon Chan Hok-fung and a reply by the Secretary for Health, Professor Lo Chung-mau, in the Legislative Council today (November 18):
Question:
Since the Hospital Authority (HA) implemented the public healthcare fees and charges reform (the fee reform) in January this year, I have received complaints from quite a number of people about the fees and charges. For example, patients in need of additional medication due to the rescheduling of follow-up consultations are charged attendance fees even though they have not seen a doctor. In this connection, will the Government inform this Council whether it knows:
(1) the number of cases in each of the past three years in which patients only needed to collect medication or obtain an additional supply of medication due to the rescheduling of follow-up consultations without having to see a doctor; the reasons for HA to charge attendance fees to the aforesaid patients; and the number of related complaint cases received by the authorities as at the end of last month;
(2) if HA still arranges for dedicated staff to explain on the spot the details of the new fees and charges system at present and whether it has provided ongoing training to frontline staff to ensure that they have an accurate understanding of the standards for the fees and charges; if not, the reasons for that; and
(3) given that following the fee reform, four weeks is adopted as the chargeable unit of outpatient medication, but patients are still required to pay for four weeks of medication even if the medication prescribed by doctors is for less than four weeks, the rationale for this arrangement; as the Government informed this Council earlier that it would review the chargeable unit concerned, the progress of the review, and whether the authorities will consider the introduction of an option for computing medication fees on a weekly basis?
Reply:
President,
The first phase of fees and charges reform for public healthcare came into effect on January 1 this year to strategically restructure the highly subsidised public healthcare service framework so that the limited financial and manpower resources of the public healthcare system can be used in a more targeted manner to strengthen protection for four categories of "poor, acute, serious, critical" patients, while reducing wastage and abuse.
In supporting poor patients, the reform has significantly expanded the coverage of the medical fee waiver mechanism. The number of persons granted full waivers increased from under 14 000 annually in the past to over 250 000, extending free healthcare services to more low-income families. In the first 10 months of this year, the amount of medical fees waived under the enhanced medical fee waiver mechanism was approximately $900 million.
In handling acute care services, the reform has guided patients towards more reasonable use of Accident and Emergency (A&E) services. In the first 10 months of this year, Category IV Semi-urgent and Category V Non-urgent attendances decreased by 7.0 per cent compared with the same period last year, with non-urgent cases even dropping by 17.5 per cent. Meanwhile, Category I Critical and Category II Emergency cases are fully exempted from A&E fees under the new fees and charges mechanism, involving approximately $30 million in the first 10 months. The time targets for priority treatment were fully met (with critical patients receiving immediate treatment and emergency patients receiving care within 15 minutes).
For patients with serious illnesses, the reform introduced an annual spending cap of $10,000 without requiring financial assessment to prevent members of the public from impoverishment due to illness. As of end-October, the number of patients with approved applications exceeded 24 000, with approximately $200 million in fees waived.
In respect of critical illnesses, the reform has enhanced the subsidies for innovative drugs and medical devices. The Hospital Authority (HA) has added 26 new drugs to its Drug Formulary over the past 10 months, 13 of which are subsidised by the Government, involving an estimated additional annual expenditure of about $192 million.
During the same period, 31 proposals for introducing new drugs and medical devices/relaxing clinical indications, and 26 self-financed medical devices were included under the subsidy coverage of the Samaritan Fund (SF), involving an estimated additional annual expenditure of over $130 million. The reform has also relaxed the SF's means test criteria. As compared to the same period last year, in the first 10 months of this year, the approved SF subsidies for drug and non-drug items have expanded by $350 million and $49 million respectively, representing increases of about 19 per cent and 16 per cent year-on-year to $2.2 billion and $360 million respectively.
In consultation with the HA, the reply to the question raised by the Hon Chan Hok-fung is as follows:
(1) Regarding the Hon Chan's claim that a patient may be prescribed or collect medication without having to see a doctor, the HA emphasises that this is unrelated to the fees and charges reform. Before the fees and charges reform, the HA already made available two arrangements namely the "prescription after rescheduling" and "staged medication collection". The main difference between the two lies in whether the doctor's reassessment of the patient's condition and a new prescription are needed.
Regarding "prescription after rescheduling", if a patient, for personal reasons, takes the initiative to reschedule a follow-up consultation or fails to attend a scheduled follow-up consultation, and his or her prescribed medication is insufficient to last until the next visit, he or she may apply for an additional supply of medication without a face-to-face medical consultation. To ensure the continued suitability of the prescribed medication for the patient, the doctor is still required to review the patient's medical history and assess his or her clinical condition to ascertain that the continued use of the medication is appropriate before issuing a prescription. As the above-mentioned assessment and prescription constitute consultation services, the patient is required to pay the outpatient consultation fee.
In exceptional circumstances, such as circumstances not owing to the patient's personal reasons, when clinic services are suspended due to severe weather, rendering the patient unable to attend the scheduled follow up consultation, the relevant consultation fees can be waived. The HA does not maintain statistics on the case number of "prescription after rescheduling".
"Staged medication collection" refers to the situation where prescriptions are given to clinically stable patients with longer intervals between follow-up consultations such as chronic disease patients with prescriptions of over six months of medication. Under this arrangement, the Pharmacy dispenses the prescription in stages to prevent excessive home storage and reduce the risk of inappropriate use, thereby ensuring medication safety. Patients only need to settle the associated consultation fees when they first submit the prescription. When they subsequently collect the remaining medication at regular intervals under the same prescription, no further consultation fees are required as no further medical consultation is involved.
The HA received no complaints concerning "prescription after rescheduling" in 2023 and 2024, while one such complaint was recorded in 2025 and another during the first 10 months of 2026. Of these two complaints, one involved a patient's request for rescheduling a follow-up consultation on his or her own initiative for personal reasons, and the other concerned an additional supply of medication due to the patient's failure to attend the scheduled follow-up consultation. As mentioned above, to ensure the continued suitability of the prescribed medication for the patients, even if patients do not need to see the doctors face to face, the doctors have to review their clinical records and reassess their medication needs before giving them a prescription. For this reason, the patients are required to pay the consultation fees. The hospitals concerned explained the charging arrangements and the reasons behind to the complainants and rendered appropriate assistance.
(2) Since the announcement of the reform package in March 2025, the Health Bureau and the HA have been proactively explaining the details of the fees and charges reform to the Legislative Council (LegCo), members of the public and various sectors of society, including briefing the LegCo Panel on Health Services in April 2025 and May 2026, and engaging with LegCo Members at various meetings on related topics. In addition, the HA has organised about 200 media and district briefings, patient exchange meetings, focus groups and hospital workshops, etc., alongside the production of information kits, promotional videos and booklets, to deepen patient understanding of the new fees and charges and implementation arrangements. Staff training has also been provided to ensure familiarity with the charging arrangements.
(3) Under the fees and charges reform for public healthcare, the HA has enhanced the fee structure for drug prescription by reducing the chargeable unit for each prescribed drug from 16 weeks to four weeks. The existing charging model aligns more closely with the quantity of medication dispensed to patients while taking into account administrative costs and operational efficiency.
Following the principle of progressive and orderly implementation, the HA will review the charging arrangements biennially under the established mechanism, including the charging units and model for prescribed medication.
Thank you, President.
Ends/Wednesday, November 18, 2026
Issued at HKT 15:35
NNNN